Ryvu PRMT5 inhibitors show potential best-in-class profiles, including a strong antiproliferative effect on MTAP-deleted cell lines and a good safety window versus MTAP WT cells. Ryvu’s WRN inhibitor program has demonstrated target engagement and selective potency with a synthetic lethal…



Leave a Reply

Your email address will not be published. Required fields are marked *